Plaquenil 200 mg 60 tablets
Hypoxen 250 mg 30 capsules
Prednisolone 5mg 100 tablets
Sildenafil 100 mg 20 tablets
Sialis 5 mg 14 tablets
Champix 1 mg 112 tablets
Ingavirin 90 mg 10 capsues
Ovestin 2 mg 30 tablets
Ovestin Vaginal cream 15g
Macmiror 200 mg 20 tablets
Ventolin nebula 20 ampoules
- Antibacterial medication
- Antifungal medication
- Antiviral Medication
- Cardiovascular medication
- different medication
- Hormonal medication
- Immunosuppressants and immunomodulating medications
- Nervous system
- Pain relievers and anti-inflammatory
- Respiratory system
- Treatment of diseases of the liver and gastrointestinal tract
- Treatment of sensory organs, eyesight and hearing
- Urogenital system
Piracetam 800 mg 30 tablets
De-Nol 120mg 112 tablets
De-Nol 120mg 56 tablets
De-Nol 120mg 32 tablets
finasteride 5mg 30 tablets
Itrazole 100 mg 42 capsules
furasol 15 sachets of 100 mg
Triacort OINTMENT 0.1% 10G
Urseptia 200 mg 20 capsules
Minolexin 100 mg 20 capsules
Minolexin 50 mg 20 capsules
Immard 200 mg 30 tablets
Adenuric 120 mg 28 tablets
Stugeron 25mg 50 tablets
Semax nasal drops 0.1% 3 ml
Cerebrolysin 10 ml 5 vials
Trileptal 150 mg 50 tablets
Mydocalm 150 mg 30 tablets
Ceraxon 500 mg/4 ml 5 vials
Cavinton 5 mg 50 tablets
Biloba 40 mg 60 capsules
Noopept 10 mg 50 tablets
Actovegin 200 mg 50 tablets
Persen night 10 capsules
Actovegin 2 ml 25 vials
Novo-passit 60 tablets
Mexidol 125 mg 50 tablets
Cogitum 10 ml 30 vials
Memantine 10 mg 30 tablets
Vinpotropil 60 capsules
Cerebrolysin 5 ml 5 vials
Betahistine 24 mg 60 tablets
Cortexin 10 mg 10 vials
betaserc 24 mg 20 tablets
betaserc 8 mg 30 tablets
Mexidol 125 mg 30 tablets
Manufacturer: Pharmasoft
Country of origin: Russia
General description: Antioxidant drug
Dosage form
Tablets, film-coated from white to white with kremovatam white color, round, lenticular.
Composition
etilmetilgidroksipiridina succinate 125 mg
Excipients: lactose monohydrate, povidone, magnesium stearate.
The composition of the shell: Opadry II 33G28435 white (hypromellose, titanium dioxide, lactose monohydrate, polyethylene glycol (macrogol), triacetin)
Pharmacological action
Mexidol® is an inhibitor of free radical processes, membraneelectrode having antihypoxic, stress-protective, nootropic, anticonvulsant and anxiolytic action. The drug increases organism resistance to influence of various damaging factors (shock, hypoxia and ischemia, cerebrovascular accident, alcohol intoxication and antipsychotic means (neuroleptics)).
The mechanism of action of Mexidol® due to its antioxidant, antihypoxic and membrane-protective action. It inhibits lipid peroxidation, increases the activity of superoxide dismutase, increases the ratio of lipid-protein reduces the viscosity of the membrane increases its fluidity. Mexidol® modulates the activity of membrane-bound enzymes (calcium-independent phosphodiesterase, adenylate cyclase, acetylcholinesterase), receptor complexes (benzodiazepine, GABA, acetylcholine) that enhances their capability to bind to ligands, contributes to maintaining the structural and functional organization of biological membranes, transport of neurotransmitters and improve synaptic transmission. Mexidol® increases the content in brain dopamine. Causes increased compensatory activation of aerobic glycolysis and reducing the degree of oppression oxidizing processes in the Krebs cycle in hypoxia with an increase in the content of ATP and creatine phosphate, activation energosintezirutuyu functions of mitochondria, stabilization of cell membranes.
The drug improves metabolism and blood supply of the brain, improves microcirculation and blood rheology, reduces platelet aggregation. Stabilizes the membrane structure of red blood cells (erythrocytes and platelets) in the blood. Has hypolipidemic effect, reduces total cholesterol and low density lipoprotein.
Anti-stress effect is to normalize post-stress behavior, SOMATO-vegetative disorders, recovery cycles of sleep-wakefulness, impaired learning and memory, decreasing of dystrophic and morphological changes in different brain structures.
Mexidol® has a strong antitoxic effect in withdrawal syndrome. It eliminates the neurological and neurotoxic manifestations of acute alcohol intoxication, restores normal behavior, autonomic functions, and is able to remove the cognitive impairment caused by long-term administration of ethanol and its abolition. Under the influence of Mexidol® increases the effect anxiolytic, neuroleptic, antidepressant, tranquilizers and anticonvulsants, which can reduce their dose and reduce side effects. Mexidol® improves the functional state of the ischemic myocardium. In conditions of coronary insufficiency increases collateral blood flow to ischemic myocardium and helps to preserve the integrity of kardiomiotsitov and maintaining their functional activity. Effectively restores the airway diseases in reversible cardiac dysfunction.
Pharmacokinetics
Quickly absorbed by ingestion. The maximum concentration at doses of 400 - 500mg is 3.5 - 4.0 µg/ml is Rapidly distributed to organs and tissues. The average time of retention of the drug in the body the ingestion of 4.9 - 5.2 h. Metabolised in the liver by glukuronirovania. Identified 5 metabolites: 3-hydroxypyridine phosphate is formed in the liver and involvement of alkaline phosphatase breaks down into phosphoric acid and 3-hydroxypyridine; 2-th metabolite is pharmacologically active, it is formed in large quantities and is found in the urine for 1 - 2 hours after the administration; The 3rd is excreted in large quantities in the urine; 4th and 5th - glucuroconjugated. T1/2 the ingestion - 2,0 - 2,6 h is Rapidly excreted in the urine mainly as metabolites and in small amounts in unchanged form. The most intensively excreted during the first 4 h after administration of the drug. Indicators of urine excretion of unchanged drug and metabolites have individual variability
Side effects
From the digestive system: dyspepsia.
Other: allergic reactions.
Special conditions
Effects on ability to drive vehicles and management mechanisms
During the period of treatment must be careful when driving and occupation of other potentially hazardous activities, require high concentration and psychomotor speed reactions.
Testimony
-the consequences of acute stroke, including after transient ischemic attacks in phase subcompensation as prophylactic courses;
-mild traumatic brain injury, consequences of craniocerebral injuries;
-encephalopathy of different Genesis (dyscirculatory, dysmetabolic, posttraumatic, mixed);
syndrome vegetative dystonia;
-mild cognitive disorder atherosclerotic Genesis;
-anxiety disorders with neurotic and neurosis-like States;
-coronary heart disease in the complex therapy;
-relief of withdrawal syndrome in alcoholism with the prevalence of neurosis and vegetative-vascular disorders, post-abstinent disorders;
-conditions after acute intoxication antipsychotic means;
-asthenic conditions, and also to prevent the development of somatic diseases under the influence of extreme factors and loads;
-exposure to extreme (stress) factors.
Contraindications
Acute hepatic and/or renal failure, increased individual sensitivity to the drug.
In connection with the insufficient study of the drug, child age, pregnancy, breast-feeding
Drug interactions
Mexidol® compatible with all drugs used for the treatment of somatic diseases. Increases the effect of benzodiazepine drugs, antidepressants, anxiolytics, anticonvulsants and antiparkinsonian drugs. Reduces the toxic effects of ethanol.


.